Loading
PDBj
English日本語简体中文繁體中文한국어
✖
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
Search by PDB author
4JN1
DownloadVisualize
BU of 4jn1 by Molmil
An Antidote for Dabigatran
Descriptor: GLYCEROL, anti-dabigatran Fab1, heavy chain, ...
Authors:Schiele, F, Nar, H.
Deposit date:2013-03-14
Release date:2013-03-27
Last modified:2013-07-24
Method:X-RAY DIFFRACTION (1.89 Å)
Cite:A specific antidote for dabigatran: functional and structural characterization.
Blood, 121, 2013
4JN2
DownloadVisualize
BU of 4jn2 by Molmil
An Antidote for Dabigatran
Descriptor: GLYCEROL, N-[(2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alanine, anti dabigatran Fab
Authors:Schiele, F, Nar, H.
Deposit date:2013-03-14
Release date:2013-03-27
Last modified:2015-03-11
Method:X-RAY DIFFRACTION (1.71 Å)
Cite:A specific antidote for dabigatran: functional and structural characterization.
Blood, 121, 2013
4K8R
DownloadVisualize
BU of 4k8r by Molmil
An Antibody Against the C-terminal Domain of PCSK9 lowers LDL Cholesterol Levels in vivo
Descriptor: Fab1, heavy chain, light chain, ...
Authors:Schiele, F, Nar, H.
Deposit date:2013-04-18
Release date:2013-05-08
Last modified:2019-08-21
Method:X-RAY DIFFRACTION (3.22 Å)
Cite:An Antibody against the C-Terminal Domain of PCSK9 Lowers LDL Cholesterol Levels In Vivo.
J.Mol.Biol., 426, 2014
4LKC
DownloadVisualize
BU of 4lkc by Molmil
An Antibody Against the C-terminal Domain of PCSK9 lowers LDL Cholesterol Levels in vivo
Descriptor: Fab fragment of PCSK9 antibody
Authors:Schiele, F, Nar, H.
Deposit date:2013-07-07
Release date:2013-08-14
Last modified:2014-02-12
Method:X-RAY DIFFRACTION (2.2 Å)
Cite:An Antibody against the C-Terminal Domain of PCSK9 Lowers LDL Cholesterol Levels In Vivo.
J.Mol.Biol., 426, 2014
4YGV
DownloadVisualize
BU of 4ygv by Molmil
Reversal Agent for Dabigatran
Descriptor: GLYCEROL, aDabi-Fab2a heavy chain, aDabi-Fab2a light chain
Authors:Schiele, F, Nar, H.
Deposit date:2015-02-26
Release date:2015-06-17
Last modified:2024-01-10
Method:X-RAY DIFFRACTION (1.76 Å)
Cite:Structure-guided residence time optimization of a dabigatran reversal agent.
Mabs, 7, 2015
4YHM
DownloadVisualize
BU of 4yhm by Molmil
Reversal Agent for Dabigatran
Descriptor: N-[(2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alanine, aDabi-Fab2b heavy chain, aDabi-Fab2b light chain
Authors:Schiele, F, Nar, H.
Deposit date:2015-02-27
Release date:2016-01-13
Last modified:2024-01-10
Method:X-RAY DIFFRACTION (2.16 Å)
Cite:Structure-guided residence time optimization of a dabigatran reversal agent.
Mabs, 7, 2015
4YHI
DownloadVisualize
BU of 4yhi by Molmil
Reversal Agent for Dabigatran
Descriptor: N-[(2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alanine, aDabi-Fab2a heavy chain, aDabi-Fab2a light chain
Authors:Schiele, F, Nar, H.
Deposit date:2015-02-27
Release date:2016-01-13
Last modified:2024-01-10
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:Structure-guided residence time optimization of a dabigatran reversal agent.
Mabs, 7, 2015
4YHN
DownloadVisualize
BU of 4yhn by Molmil
Dabigatran Reversal Agent
Descriptor: aDabi-Fab3 heavy chain, aDabi-Fab3 light chain
Authors:Schiele, F, Nar, H.
Deposit date:2015-02-27
Release date:2016-02-10
Last modified:2024-01-10
Method:X-RAY DIFFRACTION (2.31 Å)
Cite:Structure-guided residence time optimization of a dabigatran reversal agent.
Mabs, 7, 2015
4YHO
DownloadVisualize
BU of 4yho by Molmil
Reversal Agent for Dabigatran
Descriptor: N-[(2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alanine, aDabi-Fab3 heavy chain, aDabi-Fab3 light chain
Authors:Schiele, F, Nar, H.
Deposit date:2015-02-27
Release date:2016-01-13
Last modified:2024-01-10
Method:X-RAY DIFFRACTION (1.82 Å)
Cite:Structure-guided residence time optimization of a dabigatran reversal agent.
Mabs, 7, 2015
4YHK
DownloadVisualize
BU of 4yhk by Molmil
Reversal Agent for Dabigatran
Descriptor: GLYCEROL, N-[(2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alanine, aDabi-Fab2a heavy chain, ...
Authors:Schiele, F, Nar, H.
Deposit date:2015-02-27
Release date:2016-01-13
Last modified:2024-01-10
Method:X-RAY DIFFRACTION (2.21 Å)
Cite:Structure-guided residence time optimization of a dabigatran reversal agent.
Mabs, 7, 2015
4YHL
DownloadVisualize
BU of 4yhl by Molmil
Reversal Agent for Dabigatran
Descriptor: aDabi-Fab2b heavy chain, aDabi-Fab2b light chain
Authors:Schiele, F, Nar, H.
Deposit date:2015-02-27
Release date:2016-01-13
Last modified:2024-01-10
Method:X-RAY DIFFRACTION (2.09 Å)
Cite:Structure-guided residence time optimization of a dabigatran reversal agent.
Mabs, 7, 2015
8C7H
DownloadVisualize
BU of 8c7h by Molmil
Cryo-EM Map of the latTGF-beta 28G11 Fab complex
Descriptor: 28G11 Fab heavy chain, 28G11 Fab light chain, Transforming growth factor beta activator LRRC32, ...
Authors:Ebenhoch, R, Nar, H.
Deposit date:2023-01-16
Release date:2023-03-01
Last modified:2023-03-29
Method:ELECTRON MICROSCOPY (2.7 Å)
Cite:Anti-GARP Antibodies Inhibit Release of TGF-beta by Regulatory T Cells via Different Modes of Action, but Do Not Influence Their Function In Vitro.
Immunohorizons, 7, 2023

218853

PDB entries from 2024-04-24

PDB statisticsPDBj update infoContact PDBjnumon